Mr. Hugo Alves reports
AUXLY ANNOUNCES CLOSING OF $13.8 MILLION BOUGHT-DEAL PUBLIC OFFERING, INCLUDING FULL EXERCISE OF THE OVER-ALLOTMENT OPTION
Auxly Cannabis Group Inc. has closed its bought deal short form prospectus offering, pursuant to which the company issued 46 million units of the company at a price of 30 cents per unit for gross proceeds to the company of $13.8-million, including the full exercise of the overallotment option.
The offering was led by Mackie Research Capital Corp., as sole underwriter and sole bookrunner.
Each unit comprises one common share of the company and one-half of one common share purchase warrant of the company. Each warrant entitles the holder thereof to purchase one common share at an exercise price of 40 cents at any time up to 36 months from the closing of the offering.
The net proceeds from the offering will be used for working capital and other purposes, as described in the prospectus of the company dated Dec. 10, 2020, prepared in connection with the offering.
About Auxly Cannabis Group Inc.
Auxly Cannabis Group is an international cannabis company dedicated to bringing innovative, effective and high-quality cannabis products to the medical, wellness and adult-use markets. Auxly's experienced team of industry first movers and enterprising visionaries has secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities, and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.
We seek Safe Harbor.
© 2021 Canjex Publishing Ltd. All rights reserved.